Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China
Sponsor: Sino Medical Sciences Technology Inc.
Summary
The primary objective of this trial is to evaluate the long-term safety and efficacy of the NOVA intracranial drug-eluting stent system in "real world" patients with intracranial atherosclerotic stenosis.
Official title: To Evaluate the Safety and Efficacy of the NOVA Intracranial Drug-eluting Stent System in "real World" Patients with Intracranial Atherosclerotic Stenosis: a Prospective, Multicenter, Post-marketing Registry Clinical Study (NOVA II)
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
1000
Start Date
2023-11-16
Completion Date
2029-12-30
Last Updated
2025-04-01
Healthy Volunteers
No
Conditions
Interventions
Drug-Eluting Stents
The NOVA stent is a sirolimus-eluting stent system designed for intracranial artery stenosis with a rapid exchangeable balloon
Locations (5)
First People's Hospital of Chenzhou
Chenzhou, China
Ganzhou People's Hospital
Ganzhou, China
Jinhua Municipal Central Hospital
Jinhua, China
The First Affiliated Hospital of Ningbo University
Ningbo, China
Shanxi Cardiovascular Hospital
Shanxi, China